[5]
Al-Qudah, M.A.; Al-Dwairi, A. Mechanisms and regulation of neurotrophin synthesis and secretion. Neurosciences (Riyadh), 2016, 21(4), 306-313.
[21]
Bao, W.; Qiu, H.; Yang, T.; Luo, X.; Zhang, H.; Wan, X. Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma. PLoS One, 2013, 8(7), e70616.
[36]
Maussion, G.; Yang, J.; Yerko, V.; Barker, P.; Mechawar, N.; Ernst, C.; Turecki, G. Regulation of a truncated form of tropomyosin-related kinase B (TrkB) by Hsa-miR-185* in frontal cortex of suicide completers. PLoS One, 2012, 7(6), e39301.
[37]
Cochrane, D.R.; Howe, E.N.; Spoelstra, N.S.; Richer, J.K. Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers. J. Oncol., 2010, 2010821717.
[38]
Kopp, F.; Oak, P.S.; Wagner, E.; Roidl, A. miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression. PLoS One, 2012, 7(11), e50469.
[39]
Howe, E.N.; Cochrane, D.R.; Cittelly, D.M.; Richer, J.K. miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer. PLoS One, 2012, 7(11), e49987.
[42]
Bardelli, A.; Parsons, D.W.; Silliman, N.; Ptak, J.; Szabo, S.; Saha, S.; Markowitz, S.; Willson, J.K.; Parmigiani, G.; Kinzler, K.W.; Vogelstein, B.; Velculescu, V.E. Mutational analysis of the tyrosine kinome in colorectal cancers. Science, 2003, 300(5621), 949.
[44]
Davies, H.; Hunter, C.; Smith, R.; Stephens, P.; Greenman, C.; Bignell, G.; Teague, J.; Butler, A.; Edkins, S.; Stevens, C.; Parker, A.; O’Meara, S.; Avis, T.; Barthorpe, S.; Brackenbury, L.; Buck, G.; Clements, J.; Cole, J.; Dicks, E.; Edwards, K.; Forbes, S.; Gorton, M.; Gray, K.; Halliday, K.; Harrison, R.; Hills, K.; Hinton, J.; Jones, D.; Kosmidou, V.; Laman, R.; Lugg, R.; Menzies, A.; Perry, J.; Petty, R.; Raine, K.; Shepherd, R.; Small, A.; Solomon, H.; Stephens, Y.; Tofts, C.; Varian, J.; Webb, A.; West, S.; Widaa, S.; Yates, A.; Brasseur, F.; Cooper, C.S.; Flanagan, A.M.; Green, A.; Knowles, M.; Leung, S.Y.; Looijenga, L.H.; Malkowicz, B.; Pierotti, M.A.; Teh, B.T.; Yuen, S.T.; Lakhani, S.R.; Easton, D.F.; Weber, B.L.; Goldstraw, P.; Nicholson, A.G.; Wooster, R.; Stratton, M.R.; Futreal, P.A. Somatic mutations of the protein kinase gene family in human lung cancer.
Cancer Res., 2005,
65(17), 7591-7595.
[
http://dx.doi.org/10.1158/0008-5472.CAN-05-1855] [PMID:
16140923]
[47]
Amatu, A.; Sartore-Bianchi, A.; Siena, S. NTRK gene fusions as novel targets of cancer therapy across multiple tumour types. ESMO Open, 2016, 1(2), e000023.
[50]
Qaddoumi, I.; Orisme, W.; Wen, J.; Santiago, T.; Gupta, K.; Dalton, J.D.; Tang, B.; Haupfear, K.; Punchihewa, C.; Easton, J.; Mulder, H.; Boggs, K.; Shao, Y.; Rusch, M.; Becksfort, J.; Gupta, P.; Wang, S.; Lee, R.P.; Brat, D.; Peter Collins, V.; Dahiya, S.; George, D.; Konomos, W.; Kurian, K.M.; McFadden, K.; Serafini, L.N.; Nickols, H.; Perry, A.; Shurtleff, S.; Gajjar, A.; Boop, F.A.; Klimo, P.D., Jr; Mardis, E.R.; Wilson, R.K.; Baker, S.J.; Zhang, J.; Wu, G.; Downing, J.R.; Tatevossian, R.G.; Ellison, D.W. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
Acta Neuropathol., 2016,
131(6), 833-845.
[
http://dx.doi.org/10.1007/s00401-016-1539-z] [PMID:
26810070]
[51]
Zhang, J.; Wu, G.; Miller, C.P.; Tatevossian, R.G.; Dalton, J.D.; Tang, B.; Orisme, W.; Punchihewa, C.; Parker, M.; Qaddoumi, I.; Boop, F.A.; Lu, C.; Kandoth, C.; Ding, L.; Lee, R.; Huether, R.; Chen, X.; Hedlund, E.; Nagahawatte, P.; Rusch, M.; Boggs, K.; Cheng, J.; Becksfort, J.; Ma, J.; Song, G.; Li, Y.; Wei, L.; Wang, J.; Shurtleff, S.; Easton, J.; Zhao, D.; Fulton, R.S.; Fulton, L.L.; Dooling, D.J.; Vadodaria, B.; Mulder, H.L.; Tang, C.; Ochoa, K.; Mullighan, C.G.; Gajjar, A.; Kriwacki, R.; Sheer, D.; Gilbertson, R.J.; Mardis, E.R.; Wilson, R.K.; Downing, J.R.; Baker, S.J.; Ellison, D.W.St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas.
Nat. Genet., 2013,
45(6), 602-612.
[
http://dx.doi.org/10.1038/ng.2611] [PMID:
23583981]
[52]
Jones, D.T.; Hutter, B.; Jäger, N.; Korshunov, A.; Kool, M.; Warnatz, H.J.; Zichner, T.; Lambert, S.R.; Ryzhova, M.; Quang, D.A.; Fontebasso, A.M.; Stütz, A.M.; Hutter, S.; Zuckermann, M.; Sturm, D.; Gronych, J.; Lasitschka, B.; Schmidt, S.; Seker-Cin, H.; Witt, H.; Sultan, M.; Ralser, M.; Northcott, P.A.; Hovestadt, V.; Bender, S.; Pfaff, E.; Stark, S.; Faury, D.; Schwartzentruber, J.; Majewski, J.; Weber, U.D.; Zapatka, M.; Raeder, B.; Schlesner, M.; Worth, C.L.; Bartholomae, C.C.; von Kalle, C.; Imbusch, C.D.; Radomski, S.; Lawerenz, C.; van Sluis, P.; Koster, J.; Volckmann, R.; Versteeg, R.; Lehrach, H.; Monoranu, C.; Winkler, B.; Unterberg, A.; Herold-Mende, C.; Milde, T.; Kulozik, A.E.; Ebinger, M.; Schuhmann, M.U.; Cho, Y.J.; Pomeroy, S.L.; von Deimling, A.; Witt, O.; Taylor, M.D.; Wolf, S.; Karajannis, M.A.; Eberhart, C.G.; Scheurlen, W.; Hasselblatt, M.; Ligon, K.L.; Kieran, M.W.; Korbel, J.O.; Yaspo, M.L.; Brors, B.; Felsberg, J.; Reifenberger, G.; Collins, V.P.; Jabado, N.; Eils, R.; Lichter, P.; Pfister, S.M. International Cancer Genome Consortium PedBrain Tumor Project. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.
Nat. Genet., 2013,
45(8), 927-932.
[
http://dx.doi.org/10.1038/ng.2682] [PMID:
23817572]
[53]
Wu, G.; Diaz, A.K.; Paugh, B.S.; Rankin, S.L.; Ju, B.; Li, Y.; Zhu, X.; Qu, C.; Chen, X.; Zhang, J.; Easton, J.; Edmonson, M.; Ma, X.; Lu, C.; Nagahawatte, P.; Hedlund, E.; Rusch, M.; Pounds, S.; Lin, T.; Onar-Thomas, A.; Huether, R.; Kriwacki, R.; Parker, M.; Gupta, P.; Becksfort, J.; Wei, L.; Mulder, H.L.; Boggs, K.; Vadodaria, B.; Yergeau, D.; Russell, J.C.; Ochoa, K.; Fulton, R.S.; Fulton, L.L.; Jones, C.; Boop, F.A.; Broniscer, A.; Wetmore, C.; Gajjar, A.; Ding, L.; Mardis, E.R.; Wilson, R.K.; Taylor, M.R.; Downing, J.R.; Ellison, D.W.; Zhang, J.; Baker, S.J. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat. Genet., 2014, 46(5), 444-450.
[56]
Pattwell, S.S.; Konnick, E.Q.; Liu, Y.J.; Yoda, R.A.; Sekhar, L.N.; Cimino, P.J. Neurotrophic Receptor Tyrosine Kinase 2 (NTRK2) Alterations in Low-Grade Gliomas: Report of a Novel Gene Fusion Partner in a Pilocytic Astrocytoma and Review of the Literature. Case Rep. Pathol., 2020, 20205903863.
[58]
Jones, K.A.; Bossler, A.D.; Bellizzi, A.M.; Snow, A.N. BCR-NTRK2 fusion in a low-grade glioma with distinctive morphology and unexpected aggressive behavior. Cold Spring Harb. Mol. Case Stud., 2019, 5(2), a003855.
[71]
Götz, R.; Sendtner, M. Cooperation of tyrosine kinase receptor TrkB and epidermal growth factor receptor signaling enhances migration and dispersal of lung tumor cells. PLoS One, 2014, 9(6), e100944.
[73]
Siu, M.K.; Wong, O.G.; Cheung, A.N. TrkB as a therapeutic target for ovarian cancer. Expert Opin. Ther. Targets, 2009, 13(10), 1169-1178.
[74]
Lin, C.Y.; Chen, H.J.; Li, T.M.; Fong, Y.C.; Liu, S.C.; Chen, P.C.; Tang, C.H. β5 integrin up-regulation in brain-derived neurotrophic factor promotes cell motility in human chondrosarcoma. PLoS One, 2013, 8(7), e67990.
[79]
Iyer, R.; Wehrmann, L.; Golden, R.L.; Naraparaju, K.; Croucher, J.L.; MacFarland, S.P.; Guan, P.; Kolla, V.; Wei, G.; Cam, N.; Li, G.; Hornby, Z.; Brodeur, G.M. Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model. Cancer Lett., 2016, 372(2), 179-186.
[96]
O'Reilly, E. M.; Hechtman, J. F. Tumour response to TRK inhibition in a patient with pancreatic adenocarcinoma harbouring an NTRK gene fusion. Ann Oncol, 2019, 30(8), viii36-viii40.
